Geron | GERN - Equity Capital And Reserves

Stock Price
1.63
Daily Change
-0.02 -1.21%
Monthly
-15.98%
Yearly
-5.78%
Q1 Forecast
1.53

Geron reported $225.87M in Equity Capital and Reserves for its fiscal quarter ending in December of 2025.





Equity Capital And Reserves Change Date
Amgen USD 8.66B 961M Dec/2025
Bio Techne USD 2.01B 45.18M Dec/2025
Cassava Sciences USD 81.57M 6.4M Sep/2025
Cytokinetics USD -659.62M 138.5M Dec/2025
Esperion Therapeutics USD -301.96M 149.4M Dec/2025
Exelixis USD 2.16B 619K Dec/2025
Genmab DKK 5.3B 6M Jun/2025
Geron USD 225.87M 22.83M Dec/2025
Gilead Sciences USD 22.62B 1.16B Dec/2025
Incyte USD 5.17B 516.28M Dec/2025
MacroGenics USD 67M 20.38M Sep/2025
Novartis USD 44.75B 2.7B Sep/2025
Novavax USD -127.75M 28.92M Dec/2025